AnaptysBio
ANAB
136 hedge funds and large institutions have $963M invested in AnaptysBio in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 42 reducing their positions, and 15 closing their positions.
60% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 15
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
29% more capital invested
Capital invested by funds: $749M → $963M (+$215M)
7% more funds holding
Funds holding: 127 → 136 (+9)
0.22% more ownership
Funds ownership: 100.67% → 100.88% (+0.22%)
10% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$21M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.15M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$5.55M |
| 4 |
N
Natixis
Paris,
France
|
+$5.04M |
| 5 |
EP
Eversept Partners
New York
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$12.8M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$9.07M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.04M |
| 4 |
Millennium Management
New York
|
-$3.64M |
| 5 |
SG Americas Securities
New York
|
-$3.52M |
ANAB Hedge Fund Activity: Q4 2021 in Review
136 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2021, worth a combined $963M — up 29% from $749M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ANAB positions and 15 closed out — a net gain of 9 holders — while 38 added to existing stakes and 42 trimmed.
The largest buyer was Federated Hermes, adding an estimated $21M. The largest seller was Woodline Partners, cutting an estimated $12.8M.
- 136 institutional investors held AnaptysBio (ANAB) as of Q4 2021, up from 127 in Q3 2021.
- Funds reported $963M of AnaptysBio stock for Q4 2021, up 29% quarter-over-quarter.
- 24 funds opened new AnaptysBio positions in Q4 2021 and 15 closed out, a net change of +9 holders.
- The largest AnaptysBio buyer in Q4 2021 was Federated Hermes, an estimated $21M added.
- The largest AnaptysBio seller in Q4 2021 was Woodline Partners, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2021.